ПРОФИЛАКТИКА ГАСТРОЭНТЕРОЛОГИЧЕСКИХ ОСЛОЖНЕНИЙ ПРИ ЛЕЧЕНИИ БОЛЬНЫХ КАРДИОЛОГИЧЕСКОГО ПРОФИЛЯ
Г А Барышникова, С. А. Чорбинская, Н. А. Кудрявцева · Экспериментальная и клиническая гастроэнтерология · 2017
It is well known that in the structure of total mortality in Russia more than 57 % are cardiovascular disease (CVD). From the point of view of pathophysiology the basis of premature cardiovascular death in almost half the cases lies with atherothrombosis: the situation when the tyre is destroyed atherosclerotic plaque is formed thrombus, covering partially or totally the lumen of the vessel, and depending on the location of the lesion, the patient develops a myocardial infarction, ischemic atherothrombotic stroke, or gangrene of the lower extremities. Since the completion of the famous Framingham study, the notion of “risk factor” and therefore the concept of secondary and primary prevention of CVD. Among the drugs that have the ability to reduce CVD risk include antiplatelet agents and statins. It was during the administration of these drugs in some cases can cause serious problems.
Cited by 0 works.